| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/29/2007 | WO2006124447A3 Substituted n-arylpyrrolidines as selective androgen receptor modulators |
| 03/29/2007 | WO2006120478A3 Quinoline derivatives as neurokinin receptor antagonists |
| 03/29/2007 | WO2006060424A3 Inducible nitric oxide synthase dimerization inhibitors |
| 03/29/2007 | WO2006024841A3 Benzamide compounds |
| 03/29/2007 | WO2005109987A9 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
| 03/29/2007 | US20070073066 Method for purifying dianhydrides |
| 03/29/2007 | US20070073061 Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 03/29/2007 | US20070072912 Alicyclic-amine-substituted 4-carboxamido-benzimidazoles as parp-inhibitors and antioxidants |
| 03/29/2007 | US20070072901 1-Amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5 |
| 03/29/2007 | US20070072900 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| 03/29/2007 | US20070072874 Aminoheteroaryl compounds as protein kinase inhibitors |
| 03/29/2007 | US20070072857 Treating sleep disorders insomnia; 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(4-chloro-phenyl)-urea; restless leg syndrome, cardiovascular disorders, reducing blood clot |
| 03/29/2007 | US20070072853 Benzimidazole derivatives compositions containing them, preparation thereof and uses thereof |
| 03/29/2007 | US20070072842 6-Alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitors |
| 03/29/2007 | CA2623312A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 03/29/2007 | CA2619068A1 Imidazole compounds for the treatment of neurological disorders |
| 03/28/2007 | EP1767533A1 N-{(2-(2,6-dioxo(3-piperidyl)-1,3-dioxo-2,3-dihydro-1H-isoindolin-4-yl)methyl}cyclopropylcarboxamide as TNF inhibitor |
| 03/28/2007 | EP1765813A1 Substituted indazoles, compositions containing same, preparation and use |
| 03/28/2007 | EP1765812A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
| 03/28/2007 | EP1765811A2 2-aminoarylcarboxamides useful as cancer chemotherapeutic agents |
| 03/28/2007 | EP1765810A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 03/28/2007 | EP1765809A1 Xanthine derivatives useful as muscarinic receptor antagonists |
| 03/28/2007 | EP1765808A1 Bisarylurea derivatives useful for inhibiting chk1 |
| 03/28/2007 | EP1765803A1 Quaternary salt ccr2 antagonists |
| 03/28/2007 | EP1765790A1 Azine-carboxamides as anti-cancer agent |
| 03/28/2007 | EP1765789A1 N-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dimethylpropyl)benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
| 03/28/2007 | EP1765788A2 3-aminoindazole derivatives and their use for the treatment of sgk-associated diseases |
| 03/28/2007 | EP1765354A1 Leptomycin compounds |
| 03/28/2007 | EP1517906B1 Method for the production of 1,2,4-triazolylmethyl-oxiranes |
| 03/28/2007 | EP1353917B1 Novel process for the synthesis of 5-(4-fluorophenyl)-1-(2-((2r, 4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl)-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 03/28/2007 | CN1938388A Reversible piezochromic systems |
| 03/28/2007 | CN1938314A Tetrahydroquinoline derivatives and a process for preparing the same |
| 03/28/2007 | CN1938296A Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists |
| 03/28/2007 | CN1938293A New compounds for the inhibition of angiogenesis and use of thereof |
| 03/28/2007 | CN1938292A Cyclic amine compound and pest control agent |
| 03/28/2007 | CN1938291A Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists |
| 03/28/2007 | CN1938283A Pyridazinones as antagonists of alpha4 integrins |
| 03/28/2007 | CN1938279A Modulators of atp-binding cassette transporters |
| 03/28/2007 | CN1938031A Biaryl substituted pyrazinones as sodium channel blockers |
| 03/28/2007 | CN1935806A Method for preparing alfuzosin |
| 03/28/2007 | CN1935797A Novel bichalcophenes and their prodrugs as antiprotozoal agents |
| 03/28/2007 | CN1307175C Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 03/28/2007 | CN1307174C Imidazoquinoline derivatives |
| 03/28/2007 | CN1307159C TNF-alpha prodn. inhibitors |
| 03/28/2007 | CN1307155C Deltal-pyrrolines used as pesticides |
| 03/28/2007 | CN1306935C Vasopressin antagonist and oxytocin antagonist |
| 03/27/2007 | US7196205 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 03/27/2007 | US7196199 Phenoxypropylamine compounds |
| 03/27/2007 | US7196110 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents |
| 03/27/2007 | US7196109 Piperidine-1-carboxylic acid (6,7-difluoro-5-phenyl-1H-indazol-3-yl)amide; especially for treating neurodegenerative diseases; kinase inhibitor |
| 03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 03/27/2007 | US7196101 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 03/27/2007 | US7196100 Opioid receptor antagonists |
| 03/27/2007 | US7196094 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 03/27/2007 | US7196089 Administering to a patient a furan ring containing compound as prostaglandin E4 receptor antagonist to treat various diseases, such as migraines and headache |
| 03/27/2007 | US7196087 useful for modulating the 5-HT6 receptor, the 5-HT2A receptor, or both; useful in the treatment of certain CNS disorders such as Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's |
| 03/27/2007 | US7196080 Respiratory system disordeers; chronic obstructive pulminary disease |
| 03/27/2007 | US7195874 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures |
| 03/27/2007 | CA2251820C Substituted benzylamines and their use for the treatment of depression |
| 03/27/2007 | CA2208018C Sulfonamides |
| 03/23/2007 | CA2631096A1 Piperidine and piperazine derivatives |
| 03/22/2007 | WO2007032556A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 03/22/2007 | WO2007032371A1 Oxindole derivative as feeding control agent |
| 03/22/2007 | WO2007032362A1 Substituted cycloalkene derivative |
| 03/22/2007 | WO2007031558A1 5-amino-4-hydroxy-7- (imidazo [1,2-a] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
| 03/22/2007 | WO2007031529A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
| 03/22/2007 | WO2007006926A3 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors |
| 03/22/2007 | WO2006129120A9 Benzotriazepinone derivatives |
| 03/22/2007 | WO2006093832A3 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 03/22/2007 | US20070066824 Preparation of alfuzosin |
| 03/22/2007 | US20070066823 CCR9 inhibitors and methods of use thereof |
| 03/22/2007 | US20070066664 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses, materials for their synthesis |
| 03/22/2007 | US20070066663 disorders of the central and/or peripheral nervous system; minimal interaction with metabolic enzymes, improved selectivity, potentiation, acid resistance, bioavailibility; (3S) N-(2-Methylpropyl)-N-{[2-(trifluoromethyl)-phenyl]methyl}piperidin-3-amine; depression, urinary incontinence; pain |
| 03/22/2007 | US20070066655 Diarylmethylidene piperidine derivatives and their use as delta opiod receptor agonists |
| 03/22/2007 | US20070066652 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 03/22/2007 | US20070066623 Entry inhibitors of the hiv virus |
| 03/22/2007 | US20070066622 2-(3-Phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses |
| 03/22/2007 | US20070066613 (S)-2-[2-(3,5-Difluoro-phenyl)-acetylamino]-pentanoic acid {1-[2-(3-ethoxy-propylamino) -ethyl]-1H-imidazol-4-yl}-amide, having beta-amyloid peptide production inhibitory activity, used for the treatment of neurodegenerative disorders such as Alzheimer's disease |
| 03/22/2007 | US20070066610 (S)-4-Bromo-3-[(2-2,3-dihydro-benzofuran-5-yl-acetyl)-hydrazono]-2-oxo-2,3-dihydro-1H-indole-6-carboxylic acid [3-(2-hydroxymethyl-pyrrolidin-1-yl)-propyl]-amide; for treating conditions such as cancers and other cell proliferative disorders |
| 03/22/2007 | US20070066607 5-[R-2-(1S,2S-2-Cyclohexylcyclopentylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one, useful for treating conditions that are prevented or alleviated by activation of the adrenergic recptors |
| 03/22/2007 | US20070066606 Benzylbenzimidazolyl derivatives |
| 03/22/2007 | US20070066587 Substituted azetidine compounds, their preparation and use as medicaments |
| 03/22/2007 | US20070066585 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 03/22/2007 | US20070066573 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 03/22/2007 | US20070066542 Novel imidazole derivatives, their preparation and their use as medicaments |
| 03/22/2007 | US20070065898 Fluorescence polarization assays for binding of caspase inhibitors and probes therefor |
| 03/22/2007 | CA2622372A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
| 03/22/2007 | CA2622082A1 5-amino-4-hydroxy-7- (imidazo [1,2-a] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
| 03/22/2007 | CA2621292A1 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity |
| 03/21/2007 | EP1764366A2 Thrombin receptor antagonists |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1764101A1 Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments |
| 03/21/2007 | EP1763526A1 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
| 03/21/2007 | EP1763518A1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 03/21/2007 | EP1763514A2 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
| 03/21/2007 | EP1763351A2 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 03/21/2007 | EP1763347A2 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 03/21/2007 | EP1763303A1 Substituted pyridazine carboxamides and derivatives thereof |
| 03/21/2007 | EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 03/21/2007 | EP1451177B1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |